Govt tightens export ban norms for anti-malarial drug hydroxychloroquine Medical Dialogues Bureau6 April 2020 4:30 AM GMTNew Delhi: The government has tightened the export ban norms on anti-malarial drug hydroxychloroquine by including special economic zones (SEZs) under ...
South Korean coronavirus test kit makers win USFDA pre-approval Medical Dialogues Bureau30 March 2020 10:16 AM GMTSeoul: Three Korean coronavirus test-kit makers have won preliminary approval from the U.S. Food and Drug Administration (FDA), paving the way for kits...
Gilead puts emergency access to experimental coronavirus drug on hold amid surging demand Medical Dialogues Bureau24 March 2020 7:05 AM GMTThe drugmaker said in a statement there had been an exponential increase in so-called compassionate-use requests for the drug
GE Healthcare to produce ventilators round-the-clock to meet coronavirus-led demand Medical Dialogues Bureau22 March 2020 8:17 AM GMTGE did not disclose how many additional ventilators it expected to produce or the number of people it plans to hire.
US shows interest in potential coronavirus vaccine developer CureVac, Germany stakes claim Medical Dialogues Bureau17 March 2020 7:30 AM GMTBerlin: Germany staked its claim Sunday to ongoing work into a vaccine against the coronavirus, after media reports claimed US President Donald Trump w...
Trump administration scraps key plan to reduce US drug prices Medical Dialogues Bureau12 July 2019 3:30 AM GMTThe decision represents a new setback to U.S. President Donald Trump's efforts to deliver on a pledge to lower drug prices for consumers before the Nov...
Abbvie finalizes deal to buy Botox maker Allergan for $63 billion Medical Dialogues Bureau26 Jun 2019 4:30 AM GMTA note from Moody's affirmed Abbvie's debt rating, saying a plan to reduce debt through existing blockbusters like AbbVie's Humira and Imbruvica and Al...
Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report Meghna A Singhania26 May 2019 12:43 PM GMTShanghvi estimates that Sun Pharma has invested about $1 billion in its patented-drug programme so far. He says growth in the Indian generics business,...
Washington: Drugmakers will have to reveal medicine prices in TV ads Medical Dialogues Bureau10 May 2019 3:40 AM GMTHealth and Human Services Secretary Alex Azar said the Trump administration has finalized regulations that will require drug companies to disclose list...
OxyContin maker Purdue Pharma exploring bankruptcy: Report Farhat Nasim5 March 2019 3:50 AM GMTSales of OxyContin and other opioids have fallen amid public concern about their addictive nature, and as restrictions on opioid prescribing have been ...
New York City launches $100 million universal health insurance program Medical Dialogues Bureau9 Jan 2019 3:30 AM GMTNEW YORK: New York City recently launched a $100 million health insurance program to cover 600,000 uninsured city residents, including those unable to ...
Pfizer to raise US drug prices in January after previously backing down under Trump pressure Medical Dialogues Bureau19 Nov 2018 7:44 AM GMTNEW YORK: Pfizer Inc has recently announced that it plans to hike U.S. prices on 41 of its medicines in January, after walking back its previous...
